LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics.



London, UK

LabGenius

At Kindred we align our ambitions and achievements with our portfolio - in structure and in spirit. Every entrepreneur we invest in becomes a co- owner of the fund. We call it ‘equitable venture’. We invest early and work with our community of founders and advisers to help founders get further, faster from the very beginning.

Search jobs within our portfolio